Truist Raises Flywire Price Target After Strong Q1 Revenue Beat and Guidance Boost Navigating the 2026 Housing Market Key Strategies for Prospective Homebuyers Bitcoin Retreats to 74500 Poised for Weekly Decline as Geopolitical Concerns Mount New to The Street Broadcasts Episode 753 Featuring Virtuix Holdings Medicus Pharma YY Group Holding and FreeCast on Bloomberg Television Turkish Tourists Flock to Greece as Rising Costs Deter Greek Travelers to Turkey Tax Season 2025 New Rules Offer Savings for Online Sellers and EV Buyers MH Q1 2026 Earnings EPS Surges 18455 Above Estimates Stock Retreats on Uncertain Outlook CBLL Q1 2026 Earnings EPS Misses Estimates Revenue Data Unavailable Stock Edges Lower VLN Q1 2026 Earnings NarrowerThanExpected Loss Drives Share Rally PONY Q4 2025 Earnings EPS Beats Estimates Revenue Not Reported Stock Declines SBSW Q2 2022 Earnings EPS Misses Estimates Amid Operational Challenges PAYO Q1 2026 Earnings EPS Surpasses Estimates by 3245 as Core Growth Momentum Continues 908 Devices MASS Surges 944 Momentum Builds Near Key Resistance Wen Acquisition Corp Warrant WENNW Holds Steady at 036 as Stock Waits for Catalyst ING Group Holds Steady at 3123 as European Bank Sector Faces Mixed Signals Qnity Electronics Q Pulls Back 33 as Resistance Holds VGM Advances 126 as Muni Bond Trust Nears Key Resistance at 1078 Inflation Pressures Persist Ahead of Memorial Day Weekend With Travel and Food Costs Rising Most Camden National Corporation CAC Q1 2026 Earnings EPS Beats Estimates Amid Slightly Negative Market Reaction Perfect Moment Ltd PMNT Slips Nearly 4 as Stock Tests Key Support Levels TuHURA Biosciences Inc HURA Rises 684 as Price Tests Key Resistance Level Philip Morris International Edges Lower as Stock Consolidates Near Key Levels Amicus Therapeutics FOLD Holds Steady Near Support as Biotech Sector Waits for Catalyst Neuphoria Therapeutics NEUP Holds Steady Near Support Can the Range Hold Puma Biotechnology PBYI Edges Higher Amidst Key Support and Resistance Levels Core Molding Technologies CMT Edges Higher Amid Consolidation Phase Phathom Pharmaceuticals PHAT Faces Selling Pressure Nears Key Support After 216 Decline